196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. (25th November 2018) - Yoshikawa, A; Kawamoto, Y; Yuki, S; Nakano, S; Sawada, K; Muranaka, T; Nakatsumi, H; Harada, K; Kobayashi, Y; Miyagishima, T; Saiki, T; Ishiguro, A; et al.